Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Being a rare condition, the incidence of chylothorax among neonates is low, but the mortality rate is high. In a dire effort to reduce the risk of death, octreotide treatment is used to effectively treat acquired and congenital chylothorax. Octreotide is proven to effectively treat chylothorax in pr...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.3233/NPM-200644
データ提供：米国国立医学図書館（NLM）
Neonatal Chylothorax: A Tiny Oasis in a Storm
Neonatal chylothorax, a rare but potentially life-threatening condition, presents a unique challenge in the field of neonatology. This review article explores the use of high-dose octreotide for managing neonatal chylothorax, a treatment approach that has shown promise in reducing the risk of mortality. The authors delve into the effectiveness of octreotide in both preterm and full-term neonates, examining the optimal dosage and administration methods. The review concludes by emphasizing the importance of continued research to optimize the use of high-dose octreotide for this challenging condition.
High-Dose Octreotide: A Potential Oasis in the Desert of Neonatal Chylothorax
This review suggests that high-dose octreotide may be a valuable tool for managing neonatal chylothorax. The authors highlight the potential benefits of this treatment approach, including a reduction in mortality rates. The findings of the review provide a strong rationale for further investigation into the optimal dosage and administration methods of high-dose octreotide for this complex condition. The authors also acknowledge the importance of ongoing research to optimize the use of octreotide for managing this rare and challenging condition.
Neonatal Chylothorax: A Tiny Oasis in a Storm
Neonatal chylothorax, a rare but potentially life-threatening condition, presents a unique challenge in the field of neonatology. This review article explores the use of high-dose octreotide for managing neonatal chylothorax, a treatment approach that has shown promise in reducing the risk of mortality. The authors delve into the effectiveness of octreotide in both preterm and full-term neonates, examining the optimal dosage and administration methods. The review concludes by emphasizing the importance of continued research to optimize the use of high-dose octreotide for this challenging condition.
Dr.Camel's Conclusion
The use of high-dose octreotide in managing neonatal chylothorax is a promising development in the field of neonatology. While further research is necessary to refine the dosage and administration strategies, the review provides valuable insights into the potential benefits of this treatment approach for this complex and challenging condition.
Date :
- Date Completed 2021-12-10
- Date Revised 2021-12-14
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.